India’s largest corporate hospital group Apollo Hospitals posted a net profit of Rs 54.7 crore in the December quarter, which was up 25 percent as compared to Rs 43.8 crore of comparable previous quarter. Its total revenue during the latest quarter was Rs 2490.8 crore.
According to the company, the third quarter has traditionally been a low season due to festival holidays, however, this year, it has been able to register a good performance, both in the hospitals and in the pharmacy division. The performance is primarily driven by a healthy result from our Mature hospitals, which reported revenue growth of 14 percent. The group was able to significantly accelerate revenue growth vis-à-vis volume growth this quarter, it said in a Saturday statement.
The company emphases that it still has significant headroom for growth at current capacities.
“Of the total 7,200 plus operating beds (excluding AHLL & Managed beds) that we have group-wide, 14 hospitals with over 1809 operating beds are new and increased utilisation and volumes in these will aid growth and further margin expansion,” the statement said.
Apollo had on January 25 opened its newly introduced Proton Cancer Centre in Chennai.
“We are proud to announce the launch of our Proton Cancer Centre, an advanced technology for radiotherapy, first of its kind in South east Asia. Our investment in Proton re-affirms our commitment of putting the patient first, leveraging new technologies and elevating health outcomes. This also adds to our armoury in our ongoing and committed war against NCDs.
The hospital group, which is present in almost all the states across the country, is entering Kerala soon.
“We also announced our foray into Kerala, with an operations management contract for a 250 bed super-specialty hospital in Cochin. This would help bolstering our Pan-India presence and provide us opportunities to increase our Medical Value Travel offerings to International patients,” Reddy said while announcing the December quarter results.